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Abstract
The origins of the ‘‘endocrine disrupter hypothesis’’
may be traced to reports on adolescent daughters born
to women who had taken the highly potent synthetic
estrogen, diethylstilbestrol, while pregnant, and who
developed a rare form of vaginal cancer and adenocar-
cinoma. Bisphenol A (BPA) is an estrogenic chemical
that is highly employed in the manufacture of a wide
range of consumer products. Some observational
studies have suggested that the amounts of BPA to
which we are exposed could alter the reproductive
organs of developing rodents. We examined the influ-
ence of BPA at low doses to address the questions of (a)
whether in utero exposure affects the vagina of the
offspring and (b) which mechanisms cause the toxic
effects. Gravid Sprague-Dawley dams were adminis-
tered either 0.1 ( low dose) or 50 mg/kg per day BPA, the
no observed effect level, or 0.2 mg/kg per day 17 -
ethinyl estradiol by gavage. Striking morphological
changes were observed in the vagina of postpubertal
offspring leading us to examine vaginal estrogen
receptor (ER) expression because BPA binds to the
ER, which is important for growth of the vaginal
epithelium. We show that the full - length ER is not
expressed during estrus in the vagina of female off-
spring exposed to either dose of BPAwhen compared to
the control group, whereas ER expression does not
differ from the control group during the diestrus stage.
ER downregulation seems to be responsible for the
observed altered vaginal morphology.
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Introduction
Endocrine-disrupting industrial chemicals (EDCs) are
released into the environment and interfere with normal
hormonal processes. Some of these chemicals can produce
toxic effects at surprisingly low doses. Many researchers
hypothesize that exposure to these EDCs during critical
periods of development, i.e., early postnatal or in utero, could
result in adverse effects to wildlife and humans [1,2].They
may influence growth, reproduction, and development.
The origins of the ‘‘endocrine disrupter hypothesis’’ may be
traced to reports on adolescent daughters born to womenwho
had taken the highly potent synthetic estrogen, diethylstilbes-
trol (DES), while pregnant. These daughters developed a
wide range of reproductive tract abnormalities, including a
rare form of vaginal cancer, vaginal adenocarcinoma [3].
Bisphenol A (BPA) is a chemical that has been widely
discussed as a prime candidate for endocrine disruption. BPA
is composed of two unsaturated phenolic rings that resemble
DES. It is among those estrogenic industrial compounds that
are highly and widely used in the manufacture of epoxy,
polyester-styrene, and polycarbonate resins and which are
used for the manufacture of dental fillings, baby bottles, and
food packaging. The ability of BPA to migrate from polymer to
food has been described [4,5 ]. In vitro studies demonstrated
that BPA binds to the estrogen receptors (ERs), induces
estrogen-dependent gene expression/ responses and is
weakly estrogenic when compared to 17 -estradiol (E2) or
DES [6-8].
Minuscule amounts of EDCs were shown to alter the
reproductive organs of developing mice [9,10], sparking
alarm within the scientific community and regulatory agen-
cies. Fred vom Saal’s group at the University of Missouri,
Columbia showed that early developmental exposure to low
doses of DES increased prostate weight in offspring, but
levels above this had the opposite effect [11]. A second study
by vom Saal showed even more disturbing effects. It
demonstrated that exposure of female mouse fetuses to a
very low dose of BPA alters their postnatal growth rate and
results in precocious puberty [12]. They found significantly
reduced number of days between vaginal opening and first
vaginal oestrus. Alarmed about the implications of these
results, some laboratories, mainly industrial ones, tried to
reproduce these data but failed [13-15]. Faced with
conflicting studies and aware of other new research that
might resolve the question, the Environmental Protection
Agency (EPA) enlisted the help of an expert panel, which met
and conducted an extensive review of raw data from
submitted studies [16]. The expert panel finally concluded
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that some estrogenic chemicals can cause biologic effects at
levels below those normally found safe. Discrepancies
between the studies may be attributed to variable sensitivity
to estrogenic chemicals by laboratory animals. Indeed, a
study has demonstrated that rodent strains can vary
dramatically in their response to estrogenic compounds
[17]. Furthermore, the issues of dose and binding affinities to
the ERs seem to be the heart of the controversy regarding
xenoestrogens. Pointing to these uncertainties, the expert
panel recommended new screening and testing procedures
because traditional toxicology tests, particularly standard
reproductive and developmental assays, appear to be
inadequate for screening programs. The scope of the new
testing program should include assays for (1) in vitro and in
vivo screening of ER expression and functions and (2)
genetic analysis. Robert Kavlock, director of the reproductive
division of the National Health and Environmental Effects
Research Laboratory at the U.S. EPA, currently stated that
the inconclusive results concerning effects of BPA on
reprotoxicology, can only be solved by understanding the
mechanisms [2].
We examined the influence of BPA on several reproduc-
tive endpoints during early development and adulthood at
low doses to address the questions of (1) whether in utero
exposure interferes with the reproductive system of the
offspring and (2) what are the mechanisms leading to long-
term deleterious effects after exposure of the developing
fetus to exogenous estrogens.
Materials and Methods
Female Sprague-Dawley rats with sperm-positive vaginal
smears were treated with either 2% cornstarch (Mondamin)
at 10 ml /kg per day, 0.1 mg/kg per day BPA, 50 mg/kg per
day BPA or 0.2 mg/kg per day E2. Cornstarch served as the
vehicle for BPA and pharmacological grade peanut oil was
used as the vehicle for E2. The gravid dams were treated by
gavage on gestation days 6 through 21.
Intact female offspring were maintained on a 12/12 hour
light:dark cycle, and beginning at approximately 3 months of
age, estrous cycle stage was determined by vaginal
swabbing for 3 weeks. Each estrus group contained 22
offspring in the cornstarch group, 13 offspring in the 0.1 mg/
kg per day, and 12 offspring in the 50 mg/kg per day BPA
group, as well as 19 offspring in the 0.2 mg/kg per day E2
group. The diestrus group contained 20 offspring in the
Figure 1. Representative histology of the rat offspring vagina at estrus. (A ) Control ( cornstarch - treated animals ) group. The vaginal epithelium is formed by 6–10
layers, of which superficial layers are cornified (# ).400. (B ) Rat vagina at estrus. 0.1 mg / kg BPA. No keratinization of the superficial layers (# ). Vaginal epithelium
is formed by less then four layers. 400 (C ) Rat vagina at estrus. 0.2 mg / kg E2 (positive control ). No keratinization at the surface of the epithelium (# ). Slight
desquamation of the superficial layers ( * ). Vaginal epithelium is formed by6 layers.400. (D ) Rat vagina at estrus. 50 mg / kg BPA. Process of slight keratinization
at the surface of the superficial layers (# ). Mostly no keratinization can be observed. Vaginal epithelium is formed by 6 layers. 400.
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cornstarch group, 8 offspring in the 0.1 mg/kg per day and
6 offspring in the 50 mg/kg per day BPA group, as well as
5 offspring in the 0.2 mg/kg per day group. At approximately
4 months of age, female offspring were killed by decapitation
in either estrus or diestrus between 0930 and 1600 hour of
each day. Body weight and reproductive organ and liver
Figure 2. Representative Western blot analyses of ER expression of vaginal protein during the estrous cycle of female Sprague -Dawley offspring exposed to BPA
in utero. Gravid dams were fed by gavage on gestation days 6 through 21 with either 2% cornstarch (negative control; CO ) at 10 ml / kg per day, 0.1 mg / kg per day
BPA (BPA 0.1 ), a low dose, or 50 mg / kg per day BPA (BPA 50 ), the NOEL, or 0.2 mg / kg per day E2 (0.2 E2 ), used as a positive control. The female offspring were
then sacrificed either in estrus or diestrus at 4 months of age. (A ) The full - length ER variant at 64 kDa is not expressed during estrus at the protein level in the
vagina of all female offspring exposed to either dose of BPA compared to the negative control group, whereas ER expression does not differ to the negative control
group during the diestrus stage. The anti –ER antibody reacted specifically with three bands at 64, 56, and 42 kDa from homogenates of rat vagina from control
animals (CO ). (B ) Offspring exposed to 0.2 mg E2 / kg body weight during gestation showed either a decreased or no expression of the full - length ER variant at
64 kDa in their vagina during the estrus phase compared to the negative control group (CO). In contrast to the BPA group the 42 - kDa variant of the ER is
expressed during estrus in the vagina of all offspring exposed to 0.2 mg E2 / kg body weight. The expression of the ER variants was decreased compared to the
negative control group during the diestrus stage. Protein loading was normalized to  - actin using a monoclonal primary antibody at 1:15,000 (Sigma, Deisenhofen,
Germany ), which was specific for a band at 42 kDa (A and B ).
100 Low Doses of Bisphenol A Exposure Affect Rat Vagina Scho¨nfelder et al.
Neoplasia . Vol. 4, No. 2, 2002
weights were determined. Animals were maintained in
accordancewith theGuide for theCare andUseof Laboratory
Animals from the physiological society of Germany. BPA was
purchased from Sigma-Aldrich Chemicals (Steinheim, Ger-
many) and E2 from Aldrich Chemical (Milwaukee, WI).
Histology
Vaginal tissue was fixed in Bouin solution, embedded in
paraffin, and sectioned at 3 m. After processing tissue
sections were stained with hematoxylin and eosin for light
microscopy. The thickness of vaginal epithelium and the
number of vaginal epithelial cell layers were measured using
a microscope (Axiophot, Zeiss, Go¨ttingen, Germany) and
the public domain Scion image analysis software (Scion
Image 1.62c MacOs, Scion, Frederick, MD).
Western Blot Analyses
Western blot analyses were performed on vaginal tissue
of each in utero treated offspring. Homogenization of rat
vaginal tissue samples was performed for 15 minutes in an
ultrasonic bath on ice in homogenization buffer including a
cocktail of protease inhibitors (complete; Boehringer
Mannheim, Germany). Homogenates were centrifuged at
20,000g for 30 minutes. The resulting supernatants were
retained for further experiments. Protein concentrations
were determined in triplicate according to Bradford using
BSA as a reference standard. Fifteen micrograms protein
was separated by SDS-PAGE using 10% gels and then
electrotransferred to nitrocellulose membranes using a
semidry blot transfer method. The quality as well as equal
loading of protein blots was determined by Ponceau S
staining of nitrocellulose and using a monoclonal antibody
against  -actin (Sigma, Germany) at 1:15.000. Blots were
incubated overnight with polyclonal antibodies against ER
(MC-20, sc-542; Santa Cruz, Heidelberg, Germany) at a
1:100 dilution. The Mr of the immunoreactive bands were
determined using molecular weight marker protein stocks
SDS-PAGE 7b (Sigma, Germany). After washing, blots
were incubated for 90 minutes with anti - rabbit or anti -mouse
IgG-conjugated peroxidase antibody at a 1:5000 dilution
(Biogenes, Berlin, Germany). Blots were finally rinsed, and
immune complexes were visualized using ECL reagent
(Amersham, Freidburg, Germany). Specificity of the ob-
tained immunoreactive bands was assessed by using
peptide absorbed antiserum against ER -peptide (MC-20,
sc-542P; Santa Cruz).
Results
Histology of Vaginal Epithelium
Striking morphologic changes in the differentiation,
stratification, and cornification of the vaginas could be
observed during estrus from the same in utero treated
animals when compared to the negative control group
(Figure 1A ). No keratinization at the surface of the
epithelium was observed following exposure to 0.1 mg/kg
BPA (Figure 1B ) when compared to the control group
(Figure 1A ). The thickness of the total epithelium was
reduced following exposure to 0.1 mg/kg BPA (Figure 1B )
when compared to the control group (Figure 1A ). The 50-mg
dose caused a similar effect, but was less pronounced
(Figure 1D ). Exposure to 0.2 mg/kg E2 (positive control;
Figure 1B ) resulted in a morphologic picture similar to the
0.1 mg/kg BPA group (Figure 1B ) with slight desquamation
of the superficial layers. In diestrus, no major differences of
the vaginal epithelium could be observed between the
control and treated animals (data not shown).
We could not observe any further morphological and
structural changes of the vagina in offspring.
Western Blot Analyses
We clearly demonstrate that the full - length ER variant at
64 kDa is not expressed during estrus at the protein level in
the vagina of all female offspring exposed to either dose of
BPA compared to the negative control group, whereas ER
expression does not differ from the control group during the
diestrus stage (Figure 2A ). The anti–ER antibody specif-
ically reacted with three bands at 64, 56, and 42 kDa from
homogenates of rat vagina from control animals (Figure 2A ).
Offspring exposed to 0.2 mg E2/kg body weight during
gestation showed either a decreased or no expression of
ER in their vagina during estrus (Figure 2B ). Binding to all
immunopositive bands was eliminated when antibody was
preincubated with antigen peptide (not shown).
In addition, we could not observe ER expression at the
protein level in the rat vaginal tissue from any group (data not
shown).
Discussion
Vaginal epithelium cornifies or mucifies in response to the
changing levels of circulating steroids during the estrous
cycle [18]. Estrogens stimulate vaginal epithelium prolifer-
ation in vivo [19] and play a critical role in vaginal growth,
epithelial morphogenesis, cytodifferentiation, and secretory
activity. EDCs have been suspected to have adverse
environmental effects because prenatal exposure to DES,
another synthetic estrogen, was reported to be associated
with clear cell adenocarcinoma of the vagina in female
offspring. We performed Western blot analyses to study the
expression of ERs and their variants in the vagina of
4-month-old (postpubertal ) offspring exposed to BPA in
utero, because ER expression is important for growth,
differentiation, and cornification of the vaginal epithelial cells
[20]. The expression of ER was investigated because we
recently demonstrated [21] that those in utero treated
animals exhibited altered times to vaginal opening and
striking morphologic changes in the differentiation, stratifi-
cation, and cornification of the vaginas during estrus.
Western blot analyses were used to elucidate the possible
mechanisms for the effects we observed in our observational
studies. For the first time, we clearly demonstrate that the
full - length ER variant at 64 kDa is not expressed during
estrus at the protein level in the vagina of all female offspring
exposed to either dose of BPA compared to the negative
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control group, whereas ER expression does not differ from
the control group during the diestrus stage (Figure 2A ). The
anti–ER antibody specifically reacted with three bands at
64, 56, and 42 kDa from homogenates of rat vagina from
control animals (Figure 2A ). These shorter bands (56 and
42 kDa) are derived from the alternative usage of initiation
ATG or splicing [22,23]. Specificity of immunoreactivity was
analyzed by using peptide-preabsorbed antibodies. Fur-
thermore, offspring exposed to 0.2 mg E2/kg body weight
during gestation showed either a decreased or no expression
of ER in their vagina during estrus (Figure 2B ). Our
findings clearly indicate that in utero exposure, not neonatal
exposure [24], of rats to low doses of BPA, similar to
amounts typically found in the environment, elicits long- term
changes in ER expression. BPA significantly downregu-
lates the expression of ER leading to our findings showing
striking morphologic changes in the differentiation and
cornification of vaginas. Our data are consistent with
previous reports showing a downregulation of ER expres-
sion in the uterus after neonatal exposure to DES [24,25].
The mechanisms underlying the downregulation of ER
expression may be complex, as is the case with the tissue-
specific agonist /antagonist action of tamoxifen [26]. BPA
may antagonize the action of endogenous estrogens
because there are differences in the existence of tissue-
specific ER coactivators [27]. Adult organisms have com-
pensatory mechanisms that may minimize disturbances;
these mechanisms may be imperfect in the very young or
unborn who are still in the process of developing homeo-
stasis and undergoing genetic imprinting.
In summary, this is the first study that shows that the full -
length ER is not expressed during estrus in the vagina of
female offspring exposed in utero to either dose of BPAwhen
compared to the control group, whereas ER expression
does not differ to the control group during the diestrus stage.
ER downregulation seems to be responsible for the ob-
served altered vaginal morphology.
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